Cumberland Pharmaceuticals Inc SEC filings CPIX

Cumberland Pharmaceuticals Inc has 1,000 filings in SEC EDGAR's recent list, going back to Mar 18, 2009. Its latest annual report, Form ARS, was filed on Mar 12, 2026 for the period ended Mar 12, 2026. The latest quarterly report (Form 10-Q) was filed on Aug 7, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 26, 2026 (regulation fd disclosure, other events). The company's fiscal year ends on December 31.

Cumberland Pharmaceuticals Inc SEC filings
Form Description Filed Period
424B5 Prospectus supplement Feb 14, 2025 —
424B5 Prospectus supplement Mar 20, 2024 —
S-3 Shelf registration Dec 14, 2023 —
S-8 Employee stock plan registration May 16, 2023 —
424B5 Prospectus supplement Dec 27, 2021 —
S-3 Shelf registration Dec 11, 2020 —
S-3/A Form s-3/a Jan 9, 2018 —
S-3/A Form s-3/a Dec 19, 2017 —
S-3 Shelf registration Nov 7, 2017 —
S-3/A Form s-3/a Oct 26, 2012 —
S-3 Shelf registration Sep 25, 2012 —
S-8 Employee stock plan registration Jan 15, 2010 —
424B4 Prospectus Aug 12, 2009 —
S-1/A Amended registration statement Jul 29, 2009 —
S-1/A Amended registration statement Jul 17, 2009 —
S-1/A Amended registration statement May 12, 2009 —
S-1/A Amended registration statement Apr 10, 2009 —
S-1/A Amended registration statement Mar 18, 2009 —

Showing 18 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
CPIX (Nasdaq)
Fiscal year ends
December 31
Incorporated in
TN
Headquarters
Nashville,, TN
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1087294

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.